Clementia Pharmaceuticals Inc (CMTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Operating Expenses | 19,746 | 14,776 | 11,133 | 13,702 | 11,975 |
| Operating Income | -19,746 | -14,776 | -11,133 | -13,702 | -11,975 |
| Interest Expense | 90 | 4 | 28 | 40 | -3 |
| Other Income | 736 | 532 | 539 | 552 | 578 |
| Pre-tax Income | -19,100 | -14,248 | -10,621 | -13,190 | -11,393 |
| Income Tax | 250 | 529 | 146 | 41 | 395 |
| Net Income Continuous | -19,350 | -14,777 | -10,768 | -13,231 | -11,789 |
| Net Income | $-19,350 | $-14,777 | $-10,768 | $-13,231 | $-11,789 |
| EPS Basic Total Ops | -0.56 | -0.46 | -0.34 | -0.42 | 20.92 |
| EPS Basic Continuous Ops | -0.55 | -0.47 | -0.34 | -0.42 | 20.92 |
| EPS Diluted Total Ops | -0.56 | -0.46 | -0.34 | -0.42 | 20.92 |
| EPS Diluted Continuous Ops | -0.55 | -0.47 | -0.34 | -0.42 | 20.92 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.46 | -0.34 | -0.42 | -0.37 |
| EBITDA(a) | $-19,693 | $-14,723 | $-11,080 | $-13,649 | $-11,920 |